Straightforward guidance about neurological symptoms, conditions, diagnostic testing, and treatment—written to help patients and families feel better prepared for what comes next.
The FDA approved an updated donanemab (Kisunla) dosing schedule that lowered brain-swelling (ARIA-E) risk while keeping efficacy. Here’s what Alzheimer’s patients should know.
This Epilepsy Awareness Month, learn the facts, bust common myths, know seizure first aid, and recognize when to see a neurologist. Care in western MD.
What’s real vs. still in development for drug-resistant epilepsy: an FDA-approved expanded VNS device plus medications in late-stage trials. Western MD care.
There are now 8 FDA-approved CGRP migraine treatments for prevention and acute relief. A plain-language guide to your options and how to choose.
Vyalev delivers Parkinson’s medication continuously through an under-the-skin pump to smooth motor fluctuations. Learn who may qualify and how to find out.
An at-home, once-weekly injectable Leqembi (lecanemab) is FDA-approved for Alzheimer’s maintenance dosing. Learn who may qualify and how to find out.
If one of these articles sounds familiar, our team can help you move from symptoms and questions to testing, diagnosis, and follow-up treatment.
11110 Medical Campus Rd Unit 151, Hagerstown, MD 21742
924 Seton Dr Suite C, Cumberland, MD 21502
(301) 797-7600
Secure online messaging, records, and follow-up access for existing patients.